$NI

This NiSource Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday

Keybanc analyst Sophie Karp initiated coverage on NiSource Inc. (NYSE: NI) with an Overweight rating and a price target of $52. Additionally, BTIG analyst Marie Thibault began coverage on Minimed Group, Inc. (NASDAQ: MMED) with a Buy rating and a $25 price target, and HC Wainwright & Co. analyst Yi Chen initiated coverage on Envoy Medical, Inc. (NASDAQ: COCH) with a Buy rating and a $2.5 price target. These inaugurate Tuesday's top analyst initiations, reflecting bullish outlooks for the respective companies.

Original reporting
Benzinga · Avi Kapoor
Published Mar 31, 2026, 11:57 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Mar 31, 2026, 12:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
This NiSource Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday — source image
Decision brief

The 30-second read

$NIBullishMed
01

Why it matters

Positive analyst sentiment could lead to short-term price appreciation, especially in energy and utility sectors.

02

Market read

The news is highly relevant for investors interested in the utilities and healthcare sectors, with potential short-term trading opportunities.

03

What to watch

Regulatory changes, macroeconomic factors, or company fundamentals could influence actual performance beyond analyst expectations.

Timing: Immediate to short-term (next 1-3 months)

Background

Recent analyst coverage indicates institutional confidence in NiSource and related companies, reflecting sector optimism.

Company-level read

Ticker impact

$NIBullishHigh confidence
Context

High relevance due to recent analyst coverage and bullish sentiment.

Expected impact

Moderate upward price movement over the next 1-3 months, estimated at 5-10%.

Evidence & confidence

Multiple analysts initiating coverage with bullish ratings indicate strong institutional interest and positive sentiment, supported by the company's fundamentals and sector outlook.

$MMEDBullishMedium confidence
Context

Moderate relevance; coverage on Minimed Group, Inc. with a Buy rating and $25 target.

Expected impact

Potential 3-7% increase in short-term price, contingent on broader market conditions.

Evidence & confidence

While the buy rating is positive, the company's smaller market presence and sector influence limit immediate impact. Broader market trends will also influence the outcome.

$COCHBullishLow confidence
Context

Low relevance; coverage on Envoy Medical, Inc. with a Buy rating and $2.5 target.

Expected impact

Minimal immediate price change; potential long-term growth if fundamentals support.

Evidence & confidence

The company's niche focus and lower liquidity reduce the likelihood of significant short-term price movements based solely on analyst coverage.

Market effects

Positive sentiment in energy and utilities sectors, potentially boosting related stocks.

Primarily US-focused, with limited international influence.

Limited; sector-specific news with minimal global market impact.

Counterpoint

Analyst optimism may be overly optimistic; potential for sector headwinds or company-specific issues to temper gains.

Key entities

  • NiSource Inc.

    A utility company providing natural gas and electricity services.

  • Minimed Group, Inc.

    A medical device manufacturer specializing in minimally invasive procedures.

  • Envoy Medical, Inc.

    A medical device company focusing on hearing restoration technologies.

Related articles

$NIMed

NiSource Q2 Earnings Call Highlights

NiSource (NYSE:NI) reaffirmed 2026 adjusted EPS guidance of $2.02 to $2.07 and base-plan adjusted EPS growth of 6% to 8% annually through 2030, plus 9% to 10% CAGR from 2026 to 2033. It expects data-center deals with Amazon and Alphabet to cut NIPSCO bills by about $1.4B, starting as early as Q4 2026, and said Indiana regulatory developments do not change its capex or earnings outlook.

$NIMedAI 8/10

NISOURCE INC. (NI): Results of Operations and Financial Condition

NISOURCE INC. (NI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ni-ex991_20260630.htm EX-99.1 Document Exhibit 99.1 FOR IMMEDIATE RELEASE August 5, 2026 FOR ADDITIONAL INFORMATION Media Investors media@nisource.com investors@nisource.com NiSource announces second quarter results • Reaffirming 2026 non-GAAP consolidated adjusted EPS

$MMEDMed

MiniMed Flex™ Now Available to Medicare and Medicare Advantage Beneficiaries

MiniMed (Nasdaq: MMED) said Medicare and Medicare Advantage beneficiaries can now access its MiniMed Flex insulin pump with the latest sensor portfolio. The compact app-controlled pump holds 300 units and uses SmartGuard technology that adjusts insulin every five minutes, day and night. MiniMed cited real-world ADA 2026 data for its MiniMed 780G system and said Instinct sensor availability is later this summer.

$COCHMedAI 8/10

Envoy Medical, Inc.: Envoy Medical Reports Positive 12-Month Data Showing Continued Improvement in Speech Perception in Study of First-of-Its-Kind Fully Implanted Cochlear Implant

Envoy Medical (NASDAQ: COCH) reported positive 12-month interim results from Stage 1 of its pivotal trial for the investigational fully implanted Acclaim cochlear implant. In 10 participants, mean CNC word recognition rose to 53.2% from a 15.2% baseline. No protocol-defined serious adverse events were reported. Stage 2 is fully enrolled.